{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:33:32Z","timestamp":1787841212025,"version":"build-2784847793"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Our study aimed to determine the prevalence of Peripheral Neuropathy (using nerve conduction studies (NCS)) in children with transfusion-dependent thalassemia aged between 5 to 18 years and to study its correlation with chronic anemia, ferritin levels, chelation status, annual transfusion requirement, deficiency of serum Vitamin B12, and Folate levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this hospital-based cross-sectional study, 100 eligible children were enrolled in a tertiary care teaching hospital in New Delhi, India. Neurological examinations focusing on peripheral neuropathy followed by NCS were performed on all the patients. Age-wise cutoff values outside of 2.5 SD of normal were taken as abnormal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>None of the children had clinical features of peripheral neuropathy, although 77% had abnormalities in NCS. Of these, 33% had pure motor nerve changes, 7% had pure sensory nerve changes, 1% had abnormal F responses, and 26% had mixed nerve changes. These changes correlated significantly with chronic anemia and duration of iron chelation but not with other factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In children with transfusion-dependent thalassemia who do not exhibit any neurological signs or symptoms, however, it is not uncommon to observe abnormal NCS at an average hemoglobin (Hb) level of less than 9.5 g\/dl. Further comprehensive case-control studies are necessary to determine if a more specific Hb target range of 9.5 to 10.5 g\/dl is appropriate and to investigate the potential impact of chelation therapy on these changes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_289_24","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T10:04:50Z","timestamp":1733479490000},"page":"5847-5852","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of peripheral neuropathy in children with transfusion-dependent thalassemia: A hospital-based cross-sectional study"],"prefix":"10.4103","volume":"13","author":[{"given":"Aniruddha","family":"Rathore","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Lady Hardinge Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Dhankar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Lady Hardinge Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmila B.","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Lady Hardinge Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvasini","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Lady Hardinge Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailaja","family":"Shukla","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Lady Hardinge Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piali","family":"Mandal","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Lady Hardinge Medical College, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,9]]},"reference":[{"key":"R1-20241210","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s12098-008-0109-3","article-title":"\u03b2-Thalassemia mutations in western India","volume":"75","author":"Sheth","year":"2008","journal-title":"Indian J Pediatr"},{"key":"R2-20241210","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0887-8994(98)00004-6","article-title":"Neurophysiologic evaluation of long-term desferrioxamine therapy in beta-thalassemia patients","volume":"18","author":"Zafeiriou","year":"1998","journal-title":"Pediatr Neurol"},{"key":"R3-20241210","first-page":"1","article-title":"Peripheral neuropathy:Not a feature of childhood thalassemia","volume":"7","author":"I\u015f\u0131kay","year":"2017","journal-title":"Ann Med Health Sci Res"},{"key":"R4-20241210","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.18203\/2320-6012.ijrms20182302","article-title":"Nerve conduction study in children with thalassemia","volume":"6","author":"Negi","year":"2018","journal-title":"Int J Res Med Sci"},{"key":"R5-20241210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/03630269.2018.1469510","article-title":"Assessment of peripheral neuropathy in patients with \u03b2-thalassemia via electrophysiological study:Reevaluation in the era of iron chelators","volume":"42","author":"Bayhan","year":"2018","journal-title":"Int J Hemoglobin Res"},{"key":"R6-20241210","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5144\/0256-4947.2006.358","article-title":"Peripheral neuropathy in thalassemia","volume":"26","author":"Sawaya","year":"2006","journal-title":"Ann Saudi Med"},{"key":"R7-20241210","first-page":"1483","article-title":"Axonal sensorimotor neuropathy in patients with b-thalassemia","volume":"E75","author":"E","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R8-20241210","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/jnnp.54.11.997","article-title":"Peripheral neuropathy in patients with beta-thalassemia","volume":"54","author":"Papanastasiou","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R9-20241210","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s12288-018-1050-x","article-title":"Polyneuropathy associated with severe iron overload and oxidative stress in b-thalassemia patients","volume":"35","author":"El-Tagui","year":"2019","journal-title":"Indian J Hematol Blood Transfusion"},{"key":"R10-20241210","first-page":"3251","article-title":"Polyneuropathy and myopathy in beta-thalassemia major patients","volume":"18","author":"Nemtsas","year":"2018","journal-title":"Ann Hematol"},{"key":"R11-20241210","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.braindev.2005.03.006","article-title":"Neurophysiologic and intellectual evaluation of beta-thalassemia patients;","volume":"28","author":"Economou","year":"2006","journal-title":"Brain Dev"},{"key":"R12-20241210","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000207658","article-title":"Auditory involvement in thalassemia major","volume":"61","author":"De Virgiliis","year":"1979","journal-title":"Acta Haematol"},{"key":"R13-20241210","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM198604033141402","article-title":"Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions","volume":"314","author":"Olivieri","year":"1986","journal-title":"N England J Med"},{"key":"R14-20241210","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2141.1989.tb07761.x","article-title":"Desferrioxamine ototoxicity:Evaluation of risk factors in thalassemic patients and guidelines for safe dosage","volume":"73","author":"Porter","year":"1989","journal-title":"Br J Haematol"},{"key":"R15-20241210","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00043426-199602000-00008","article-title":"Ototoxicity in hemoglobinopathy patients chelated with desferrioxamine","volume":"18","author":"Styles","year":"1996","journal-title":"Pediatr Hematol Oncol"},{"key":"R16-20241210","first-page":"116","article-title":"Desferrioxamine ototoxicity in an adult transfusion-dependent population","volume":"26","author":"Chiodo","year":"1997","journal-title":"J Otolaryngol"},{"key":"R17-20241210","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1006\/phrs.2000.0722","article-title":"Audiological evaluation in adult beta-thalassemia major patients under regular chelation treatment","volume":"42","author":"Ambrosetti","year":"2000","journal-title":"Pharmacol Res"},{"key":"R18-20241210","first-page":"113","article-title":"Long-term audiological evaluation of beta-thalassemic patients","volume":"58","author":"Kontzoglou","year":"2004","journal-title":"Acta Otorhinolaryngol Belg"},{"key":"R19-20241210","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MBC.0b013e32834f0ac0","article-title":"Subclinical central nervous system involvement and thrombophilic status in young thalassemia intermedia patients of Greek origin","volume":"23","author":"Teli","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R20-20241210","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/adc.63.3.250","article-title":"Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia","volume":"63","author":"Devirgiliis","year":"1988","journal-title":"Arch Dis Child"},{"key":"R21-20241210","first-page":"181","article-title":"Electrophysiological (EEG, BAEP, VEP) study in patients with beta-thalassemia major","volume":"87","author":"Amabile","year":"1987","journal-title":"Acta Neurol Belg"},{"key":"R22-20241210","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/088307389300800407","article-title":"Neurophysiologic study of beta-thalassemia patients","volume":"8","author":"Wong","year":"1993","journal-title":"J Child Neurol"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_289_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:46:19Z","timestamp":1787838379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_289_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_289_24","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"2024-02-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}